Abstract
Background The population health impacts of the COVID-19 pandemic are less well understood in low-and middle-income countries, where mortality surveillance before the pandemic was patchy. Interpreting the limited all-cause mortality data available in India is challenging.
Objective We use existing data on all-cause mortality from civil registration systems of twelve Indian states comprising around 60% of the national population to understand the scale and timing of excess deaths in India during the COVID-19 pandemic.
Methods We carefully characterize the reasons why registration is incomplete and estimate the extent of coverage in the data. Comparing the pandemic period to 2019, we estimate excess mortality in twelve Indian states, and extrapolate our estimates to the rest of India. We explore sensitivity of the estimates to various assumptions.
Results For the 12 states with available all-cause mortality data, we document an increase of 28% in deaths during April 2020–May 2021 relative to expectations from 2019. This level of increase in mortality, if it applies nationally, would imply 2.8–2.9 million excess deaths. More limited data from June 2021 increases national estimates of excess deaths during April 2020–June 2021 to 3.8 million. With more optimistic or pessimistic assumptions, excess deaths during this period could credibly lie between 2.8 million and 5.2 million. The scale of estimated excess deaths is broadly consistent with expectations based on seroprevalence data and international data on COVID-19 fatality rates. Moreover, the timing of excess deaths and recorded COVID-19 deaths is similar – they rise and fall at the same time.
Conclusions The surveillance of pandemic mortality in India has been extremely poor, with around 8–10 times as many excess deaths as officially recorded COVID-19 deaths. India is among the countries most severely impacted by the pandemic. Our approach highlights the utility of all-cause mortality data, as well as the significant challenges in interpreting it.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
N/A
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Murad Banaji (m.banaji{at}mdx.ac.uk)
Aashish Gupta (aashishgupta{at}hsph.harvard.edu).
Additional methodological details and state factsheets are available at https://www.indiacovidmapping.org/. Data and Code are available at our replication repository on GitHub: https://github.com/muradbanaji/IndiaACMdata/tree/master/NationalEstimates. We thank Jean Drèze, Ridhi Kashyap, Kiran Kumbhar, Chris Leffler, Srinivasan Ramani, Rukmini S, and Nikkil Sudharsanan for many helpful clarifications and suggestions.
The material has been reorganised, and there are new approaches to evaluating the uncertainty in the excess mortality estimates.
Data Availability
All data used in the article is available at a single location on github
